- 28 venture capital (VC) deals worth $100.9 million closed in Ireland in Q3'24, down 59 percent from Q3'23
- A diverse range of start-ups continued to attract VC funding in Ireland during Q3'24, although at relatively small deal sizes
- Top two deals from Galway-based medtech Luminate Medical and medical device company Loci Orthopaedics
- Budget 2025 measures and a new Seed and Venture Capital Scheme to foster growth and innovation
- The Q3'24 edition of the Venture Pulse report produced by KPMG analyses the latest global trends in venture capital investment data and provides insights from both a global and regional perspective. All figures cited are in USD; data for the report is provided by PitchBook.
Irish start-ups raised $100.9 million across 28 deals, representing a 59 percent drop compared to the $244 million raised in Q3'23 across 18 deals. While in Q2’24, 24 VC deals closed worth $237.5 million, including a $110 million raised by biotech SynOx Therapeutics.
Activity levels in Ireland follow the global trend, which was relatively soft in Q3’24. Global VC investment fell from a five-quarter high of $95.5 billion in Q2’24 to a nearly seven-year low of $70.1 billion in Q3’24, amid ongoing geopolitical conflicts, the continued exit drought, anticipated seasonal lulls in investment in several key jurisdictions, and the uncertainty driven by the upcoming US presidential election.